Stockscreener 앱 받기
116.64
1.36%
1.57
시장 영업 전:
117.17
0.53
+0.45%
Agilent Technologies Inc 주식(A)의 최신 뉴스
Molecular Diagnostics Market Outlook: Set to Grow at 10%+ CAGR Through 2031 as Precision Medicine and Genetic Testing Advance, Says Mordor Intelligence - GlobeNewswire Inc.
Bank of America Maintains Neutral on Agilent Technologies (A) March 2026 - Meyka
Agilent Technologies: $950 Million Acquisition Of Pathology Diagnostics Company Biocare Medical - Pulse 2.0
Agilent Technologies to acquire Biocare Medical for $950 million - The American Bazaar
Agilent to Acquire Biocare Medical in $950 Million All-Cash Deal - TradingView
Sullivan & Cromwell Advises Agilent On $950M Biocare Buy - Law360
Agilent to buy Biocare Medical for $950M - Healthcare Dive
Agilent Technologies to acquire Biocare Medical in $950m deal - Medical Device Network
BofA reiterates Agilent stock rating on Biocare acquisition - Investing.com
Agilent stock rises on $950M Biocare Medical acquisition - Investing.com South Africa
Agilent expands pathology portfolio with acquisition of Biocare Medical for $950 M - BioSpectrum India
Agilent to acquire Biocare Medical in $950 million all-cash deal - PharmaLive
Sienna Gestion Sells 26,245 Shares of Agilent Technologies, Inc. $A - MarketBeat
Victory Capital Management Inc. Boosts Stake in Agilent Technologies, Inc. $A - MarketBeat
Hims & Hers shares soar premarket; Pfizer, Agilent Technologies slip - Investing.com
Agilent to acquire Biocare Medical for $950M, expanding pathology portfolio - MSN
Agilent Technologies to Acquire Biocare Medical in $950 Million Deal - marketscreener.com
Agilent Bets On Pathology Innovation With Biocare Acquisition - Benzinga
Agilent to Acquire Biocare Medical, a Global Leader in Clinical and Research Pathology Solutions - 01net
M&A News: Agilent to Buy Biocare Medical for $950M — What Investors Should Know - TipRanks
Agilent Technologies, Inc. (NYSE:A) entered into a definitive agreement to acquire Biocare Medical, LLC from an investor group led by Excellere Capital Fund III LP, a fund managed by Excellere Capital Management LLC and GHO Capital Partners LLP for ap - marketscreener.com
Why Agilent Stock Is Slipping Premarket Today - Stocktwits
Excellere Partners and GHO Capital Sell Biocare Medical to Agilent Technologies - National Today
Agilent to buy Biocare Medical in $950 million all-cash deal - marketscreener.com
Agilent Buys Medical Instruments Maker Biocare for $950 Million - Bloomberg
Neo Ivy Capital Management Takes $1.20 Million Position in Agilent Technologies, Inc. $A - MarketBeat
Dimensional Fund Advisors LP Purchases 346,428 Shares of Agilent Technologies, Inc. $A - MarketBeat
Agilent Technologies, Inc. $A Shares Sold by American Century Companies Inc. - MarketBeat
Agilent Technologies (A) Announces Retirement of Key Executive - GuruFocus
Agilent Technologies: Riding The GLP-1 Therapeutics Wave Across Global Pharmaceutical Laboratories! - Smartkarma
Agilent Technologies announces planned retirement of principal accounting officer - Investing.com
Agilent Announces Planned Retirement of Principal Accounting Officer - TipRanks
Agilent Technologies, Inc. (A) price target cut to $155 at Baird - MSN
Agilent Technologies, Inc. (A) Price Target Cut to $155 at Baird - Finviz
Complementary Methodologies For Analysis Of NISTmAb Impurities - Bioprocess Online
Lab chromatographs are getting smarter: what Agilent is quietly changing for US labs - AD HOC NEWS
Agilent Technologies Signals Steady Growth Amid Headwinds - The Globe and Mail
Agilent (NYSE: A) grows revenue 7% as earnings, cash flow tighten - Stock Titan
[Form 4] AGILENT TECHNOLOGIES, INC. Insider Trading Activity - Stock Titan
Agilent (NYSE: A) CEO surrenders 279 shares to cover RSU tax liability - Stock Titan
Agilent (NYSE: A) SVP surrenders shares to cover tax on RSU vesting - Stock Titan
Agilent Technologies (A) Analyst Rating Update: Morgan Stanley L - GuruFocus
Morgan Stanley Lowers Agilent Technologies (NYSE:A) Price Target to $160.00 - MarketBeat
Morgan Stanley Lowers Price Target on Agilent Technologies to $160 From $180, Keeps Overweight Rating - marketscreener.com
Agilent Technologies Reports Solid Q1 Earnings - National Today
Champlain Investment Partners LLC Has $114.97 Million Stock Holdings in Agilent Technologies, Inc. $A - MarketBeat
Morgan Stanley cuts Agilent stock price target on valuation multiples By Investing.com - Investing.com UK
Agilent Technologies Inc. stock underperforms Monday when compared to competitors - MarketWatch
Morgan Stanley cuts Agilent stock price target on valuation multiples - Investing.com
Assessing Agilent Technologies (A) Valuation After Recent Share Price Softness and Long Term Gains - Yahoo Finance
Investing in Agilent (A)? Don't Miss Assessing Its International Revenue Trends - Yahoo Finance
Agilent Technologies, Inc. (A) Stock Analysis: Exploring a 34.15% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
Apellis Appoints Mikael Dolsten, M.D., Ph.D., To Board - citybiz
Agilent Technologies Inc.: Why This Lab-Tech Giant Is Suddenly on Every Trader’s Radar - AD HOC NEWS
A Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Ideas Watch: Whats the beta of Agilent Technologies Inc stockJuly 2025 Snapshot & Capital Efficient Trade Techniques - baoquankhu1.vn
William Blair Investment Management LLC Has $275.19 Million Stake in Agilent Technologies, Inc. $A - MarketBeat
Agilent (A) Gets Lower Goldman Sachs Target Despite Long-Term Growth Confidence - Finviz
Agilent Technologies, Inc. $A Shares Sold by Harvest Portfolios Group Inc. - MarketBeat
Agilent Technologies, Inc. $A Shares Acquired by Findlay Park Partners LLP - MarketBeat
Agilent’s New FDA Approval And What It Could Mean For Investors - simplywall.st
Mitsubishi UFJ Asset Management Co. Ltd. Has $73.79 Million Stock Position in Agilent Technologies, Inc. $A - MarketBeat
2.33%
자본화:
|
볼륨(24시간):